CellPro sales and marketing update

The company's sales grew to $212,000 in the third quarter ended Sept. 30 from $72,000 in the quarter last year. CPRO said the improvement was due to increased worldwide demand for its Ceprate LC Laboratory Cell Separation System and initial European sales of the Ceprate SC Stem Cell Concentration System. ...